JPMORGAN CHASE & CO - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is and the CUSIP is 92686J906. A total of 4 filers reported holding VIKING THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$664,200
-71.4%
60,000
-58.1%
0.00%
Q2 2023$2,321,272
+1234619.1%
143,200
+616.0%
0.00%
Q4 2022$188
-99.7%
20,000
+174.0%
0.00%
Q1 2019$73,0007,3000.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 200$160,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 281$225,0000.02%
GROUP ONE TRADING, L.P. 279,000$2,238,0000.02%
SIMPLEX TRADING, LLC 1,310$1,050,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of VIKING THERAPEUTICS INC shareholders